D-mannose is a natural simple sugar closely related to glucose that has gained popularity as a supplement for preventing urinary tract infections. It’s found naturally in fruits like cranberries, grapes, apples, and watermelon, and is sold as a powder or capsule supplement. The basic idea behind it is straightforward: when you swallow d-mannose, most of it passes through your body unchanged and ends up in your urine, where it may prevent bacteria from sticking to the walls of your bladder.
How D-Mannose Works in the Body
D-mannose is a C-2 epimer of glucose, which means it’s nearly identical to the sugar your body uses for energy, with one small structural difference. That difference matters. Unlike glucose, d-mannose isn’t efficiently used as fuel. At least 90% of what you swallow is absorbed in the upper intestine, passes quickly into the bloodstream, and gets excreted into your urine largely unchanged. The bulk of it reaches your bladder within 30 to 60 minutes, with the remainder cleared over the following eight hours.
The theory behind its use for UTIs centers on E. coli, the bacterium responsible for the vast majority of bladder infections. E. coli uses tiny hair-like structures called fimbriae tipped with a protein called FimH to latch onto sugar-coated proteins lining the bladder wall. These are the same types of sugars (mannose-containing molecules) that d-mannose mimics. When free-floating d-mannose is present in urine, E. coli may bind to it instead of the bladder lining, allowing the bacteria to be flushed out during urination rather than establishing an infection.
What the Clinical Evidence Shows
The research on d-mannose for UTI prevention has produced genuinely mixed results, and the picture has shifted over time as higher-quality studies have been completed.
Several earlier, smaller trials were encouraging. A randomized controlled trial by Kranjčec and colleagues compared d-mannose (2 grams daily) to the antibiotic nitrofurantoin for preventing recurrent UTIs in women. Over six months, 14.6% of women taking d-mannose had a recurrence, compared to 20.4% on the antibiotic and 60.8% of women taking nothing. Another crossover trial by Porru and colleagues found that women taking d-mannose went an average of 200 days before a UTI recurrence, compared to just 52.7 days in the antibiotic group. Side effects were also lower: only 7.8% of d-mannose users reported diarrhea, versus 27.2% of those on nitrofurantoin who experienced diarrhea, nausea, or vaginal burning.
A meta-analysis pooling smaller studies found that d-mannose reduced the relative risk of recurrent UTI by 77% compared to placebo. That sounds impressive, but the individual studies were small and varied widely in design.
The largest and most rigorous trial to date, involving 598 women, told a different story. Published more recently, it found no meaningful difference in UTI recurrence between women taking 2 grams of d-mannose daily and those taking a placebo. There was no difference in the number of antibiotic prescriptions needed, UTI-related symptoms, or hospital admissions between the two groups.
Based largely on this large trial, the 2025 American Urological Association guidelines now state that d-mannose alone for prophylaxis “may not be effective in UTI prevention” and “cannot be recommended” due to insufficient evidence of clinical benefit. The guidelines do note that it is unlikely to cause harm.
How People Take It
D-mannose supplements come as a loose powder (typically mixed into water) or in capsules. In clinical studies, dosing has varied widely, from as low as 420 milligrams daily to 2 grams three times per day. The most commonly studied preventive dose is 2 grams once daily dissolved in water, taken for six months. For acute symptoms in studies, protocols typically involved higher initial doses (such as 1.5 grams twice daily for three days) followed by a tapering schedule.
Because d-mannose is classified as a dietary supplement rather than a drug, products on the market aren’t standardized. The amount of active ingredient, purity, and recommended dosing can vary between brands.
Side Effects and Safety Concerns
D-mannose is generally well tolerated. The most common side effect is mild gastrointestinal discomfort, particularly bloating or loose stools, especially at doses above what you’d get from food. In clinical trials, diarrhea was the main complaint but affected fewer than 8% of participants.
Because d-mannose is structurally similar to glucose, questions about blood sugar are common. It is absorbed more slowly than glucose and must be converted to fructose and then glucose before the body can use it, which significantly blunts the insulin response. Its glycemic index is much lower than that of table sugar. That said, some experts advise that people with diabetes should avoid d-mannose supplements as a precaution, since the long-term effects on blood sugar regulation haven’t been thoroughly studied in that population.
Safety data for pregnant or breastfeeding women is limited. Most clinical trials have been conducted in adult women who were not pregnant. For children, one small study in pediatric patients with complex urological issues found that d-mannose reduced UTI risk by 53% with few adverse effects, but this evidence is preliminary, and the data is largely extrapolated from adult research.
Where This Leaves You
D-mannose occupies an unusual space: it has a plausible biological mechanism, some positive smaller trials, and a large high-quality trial that found no benefit over placebo. For someone dealing with frequent UTIs, this can be frustrating. The supplement is inexpensive, widely available, and low-risk, which is why some urologists still discuss it as an option even after the updated guidelines. But the strongest available evidence suggests it may not work better than a sugar pill for preventing recurrent infections.
If you’re considering d-mannose, keep in mind that it has only been studied for E. coli-related bladder infections, which account for most but not all UTIs. It would not be expected to help with infections caused by other bacteria. It’s also not a treatment for an active UTI that requires antibiotics. Its potential role, if any, is as a preventive measure between infections.